Imaging enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography

Science Translational Medicine

Volumn 6, Issue 259, 2014, Pages 259ra146-

  Weinstein, Edward A ^a   Ordonez, Alvaro A ^a   DeMarco, Vincent P ^a   Murawski, Allison M ^a   Pokkali, Supriya ^a   MacDonald, Elizabeth M ^a   Klunk, Mariah ^a   Mease, Ronnie C ^a   Pomper, Martin G ^a   Jain, Sanjay K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; FLUORODEOXYSORBITOL F 18; RADIOPHARMACEUTICAL AGENT; SORBITOL; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL LOAD; BRAIN INFECTION; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LIMIT OF DETECTION; MALE; MIXED INFECTION; MOUSE; MYOSITIS; NON INVASIVE PROCEDURE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY ANALYSIS; WHOLE BODY IMAGING; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN TUMOR; CELL LINE; DRUG EFFECTS; DRUG SCREENING; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; IMMUNOCOMPETENCE; INFLAMMATION; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TEST; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; RADIOGRAPHY; SCINTISCANNING;

ANIMALS; ANTI-INFECTIVE AGENTS; BRAIN NEOPLASMS; CELL LINE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; FEMALE; HUMANS; IMMUNOCOMPETENCE; INFLAMMATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICE; MICROBIAL SENSITIVITY TESTS; MYOSITIS; POSITRON-EMISSION TOMOGRAPHY; SORBITOL; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84908430407     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3009815     Document Type: Article

References (45)

1. M. S. Donnenberg, in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, J. E. Bennett, G. L. Mandell, R. Dolin, Eds. (Elsevier Inc., Philadelphia, PA, 2010), chap. 218, pp. 2815-2833.
2. M. N. Guentzel, in Medical Microbiology, S. Baron, Ed. (University of Texas Medical Branch at Galveston, Galveston, TX, 1996), chap. 26.
3. A. Signore, A. W. Glaudemans, The molecular imaging approach to image infections and inflammation by nuclear medicine techniques. Ann. Nucl. Med. 25, 681-700 (2011).
4. 18F-FDS and its potential application in molecular imaging. Mol. Imaging Biol. 10, 92-98 (2008).
5. P. Lechat, L. Hummel, S. Rousseau, I. Moszer, GenoList: An integrated environment for comparative analysis of microbial genomes. Nucleic Acids Res. 36, D469-D474 (2008).
6. M. Yamada, M. H. Saier Jr., Glucitol-specific enzymes of the phosphotransferase system in Escherichia coli. Nucleotide sequence of the gut operon. J. Biol. Chem. 262, 5455-5463 (1987).
7. A. F. Zuluaga, B. E. Salazar, C. A. Rodriguez, A. X. Zapata, M. Agudelo, O. Vesga, Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: Characterization and applicability to diverse experimental models of infectious diseases. BMC Infect. Dis. 6, 55 (2006).
8. J. D. Chalmers, J. K. Taylor, A. Singanayagam, G. B. Fleming, A. R. Akram, P. Mandal, G. Choudhury, A. T. Hill, Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: A UK cohort study. Clin. Infect. Dis. 53, 107-113 (2011).
9. M. H. Kollef, A. Shorr, Y. P. Tabak, V. Gupta, L. Z. Liu, R. S. Johannes, Epidemiology and outcomes of health-care-associated pneumonia: Results from a large US database of culture-positive pneumonia. Chest 128, 3854-3862 (2005).
10. M. A. Garbati, A. I. Al Godhair, The growing resistance of Klebsiella pneumoniae; the need to expand our antibiogram: Case report and review of the literature. Afr. J. Infect. Dis. 7, 8-10 (2013).
11. M. McKenna, Antibiotic resistance: The last resort. Nature 499, 394-396 (2013).
12. P. Nordmann, L. Dortet, L. Poirel, Carbapenem resistance in Enterobacteriaceae: Here is the storm!. Trends Mol. Med. 18, 263-272 (2012).
13. CDC, Vital signs: Carba pen em-resistant Enterobacteriaceae. MMWR Morb. Mortal. Wkly. Rep. 62, 165-170 (2013).
14. M. Melzer, I. Petersen, Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing E. coli compared to non-ESBL producing E. coli. J. Infect. 55, 254-259 (2007).
15. D. W. Bates, K. Sands, E. Miller, P. N. Lanken, P. L. Hibberd, P. S. Graman, J. S. Schwartz, K. Kahn, D. R. Snydman, J. Parsonnet, R. Moore, E. Black, B. L Johnson, A. Jha, R. Platt, Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J. Infect. Dis. 176, 1538-1551 (1997).
16. T. Nakamura, O.Takahashi, K. Matsui, S. Shimizu, M. Setoyama, M. Nakagawa, T. Fukui, T. Morimoto, Clinical prediction rules for bacteremia and in-hospital death based on clinical data at the time of blood withdrawal for culture: An evaluation of their development and use. J. Eval. Clin. Pract. 12, 692-703 (2006).
17. R. C. Owens Jr., P. G. Ambrose, C. H. Nightingale, Eds., Antibiotic Optimization: Concepts and Strategies in Clinical Practice (Marcel Dekker, New York, ed. 1, 2005).
18. R. D. Scott, The Direct Medical Costs of Healthcare-Associated Infections in U.S. Hospitals and the Benefits of Prevention (Centers for Disease Control and Prevention, 2009).
19. B. M. Fischer, M. W. Olsen, C. D. Ley, T. L Klausen, J. Mortensen, L Hojgaard, P. E. Kristjansen, How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study. Eur. J. Nucl. Med. Mol. Imaging 33, 697-702 (2006).
20. C. König, H. P. Simmen, J. Blaser, Bacterial concentrations in pus and infected peritoneal fluid-Implications for bactericidal activity of antibiotics. J. Antimicrob. Chemother. 42, 227-232 (1998).
21. K. Jang, D. H. Lee, S. H. Lee, B. H. Chung, Treatment of prostatic abscess: Case collection and comparison of treatment methods. Korean J. Urol. 53, 860-864 (2012).
22. M. Yamamoto, T. Fukushima, K. Hirakawa, H. Kimura, M. Tomonaga, Treatment of bacterial brain abscess by repeated aspiration-Follow up by serial computed tomography. Neurol. Med. Chir. 40, 98-104; discussion 104-105 (2000).
23. R. C. Mease, C. A. Foss, M. G. Pomper, PET imaging in prostate cancer: Focus on prostate-specific membrane antigen. Curr. Top. Med. Chem. 13, 951-962 (2013).
24. M. E. Scott, R. E. Viola, The use of fluoro-and deoxy-substrate analogs to examine binding specificity and catalysis in the enzymes of the sorbitol pathway. Carbohydr. Res. 313, 247-253 (1998).
25. X. Ning, S. Lee, Z. Wang, D. Kim, B. Stubblefield, E. Gilbert, N. Murthy, Maltodextrin-based imaging probes detect bacteria in vivo with high sensitivity and specificity. Nat. Mater. 10, 602-607 (2011).
26. M. van Oosten, T. Schäfer, J. A. Gazendam, K. Ohlsen, E. Tsompanidou, M. C. de Goffau, H. J. Harmsen, L. M. Crane, E. Lim, K. P. Francis, L. Cheung, M. Olive, V. Ntziachristos, J. M. van Dijl, G. M. van Dam, Real-time in vivo imaging of invasive-and biomaterial-associated bacterial infections using fluorescently labelled vancomycin. Nat. Commun. 4, 2584 (2013).
27. F. J. Hernandez, L Huang, M. E. Olson, K. M. Powers, L. I. Hernandez, D. K. Meyerholz, D. R. Thedens, M. A. Behlke, A. R. Horswill, J. O. McNamara II, Noninvasive imaging of Staphylococcus aureus infections with a nuclease-activated probe. Nat. Med. 20, 301-306 (2014).
28. Y. Kong, H. Yao, H. Ren, S. Subbian, S. L. Cirillo, J. C. Sacchettini, J. Rao, J. D. Cirillo, Imaging tuberculosis with endogenous |3-lactamase reporter enzyme fluorescence in live mice. Proc. Natl. Acad. Sci. U.S.A. 107, 12239-12244 (2010).
29. M. L. James, S. S. Gambhir, A molecular imaging primer: Modalities, imaging agents, and applications. Physiol. Rev. 92, 897-965 (2012).
30. S.Vinjamuri, A.V. Hall, K. K.Solanki, J. Bomanji, Q.Siraj, E. O'Shaughnessy, S. S. Das, K. E. Britton, Comparison of 99mTc infecton imaging with radiolabeled white-cell imaging in the evaluation of bacterial infection. Lancet 347, 233-235 (1996).
31. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J. Nucl. Med. 45, 321-326 (2004).
32. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J. Nucl. Med. 44, 920-926 (2003).
33. 99mTc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J. Nucl. Med. 43, 239-245 (2002).
34. N. Dumarey, A. Schoutens, Renal abscess: Filling in with Tc-99m ciprofloxacin of defects seen on Tc-99m DMSA SPECT. Clin. Nucl. Med. 28, 68-69 (2003).
35. 18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur. J. Nucl. Med. Mol. Imaging 32, 143-150 (2005).
36. M. Welling, M. Stokkel, J. Balter, L. Sarda-Mantel, A. Meulemans, D. Le Guludec, The many roads to infection imaging. Eur. J. Nucl. Med. Mol. Imaging 35, 848-849 (2008).
37. P. Panizzi, M. Nahrendorf, J. L. Figueiredo, J. Panizzi, B. Marinelli, Y. Iwamoto, E. Keliher, A. A. Maddur, P. Waterman, H. K. Kroh, F. Leuschner, E. Aikawa, F. K. Swirski, M. J. Pittet, T. M. Hackeng, P. Fuentes-Prior, O. Schneewind, P. E. Bock, R. Weissleder, In vivo detection of Staphylococcus aureus endocarditis by targeting pathogen-specific prothrombin activation. Nat. Med. 17, 1142-1146 (2011).
38. C. Bettegowda, C. A. Foss, I. Cheong, Y. Wang, L. Diaz, N. Agrawal, J. Fox, J. Dick, L. H. Dang, S. Zhou, K. W. Kinzler, B. Vogelstein, M. G. Pomper, Imaging bacterial infections with radio-labeled 1-(2¢-deoxy-2¢-fluoro-b-D-arabinofuranosyl)-5-iodouracil. Proc. Natl. Acad. Sci. U.S.A. 102, 1145-1150 (2005).
39. 18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats. Nucl. Med. Biol. 31, 875-882 (2004).
40. 18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob. Agents Chemother. 53, 4879-4884 (2009).
41. S. K. Jain, P. Kwon, W. J. Moss, Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: Case report and review. Clin. Pediatr. 44, 443-450 (2005).
42. F. Sievers, A. Wilm, D. Dineen, T. J. Gibson, K. Karplus, W. Li, R. Lopez, H. McWilliam, M. Remmert, J. Söding, J. D. Thompson, D. G. Higgins, Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7, 539 (2011).
43. M. Rouse, J. M. Steckelberg, in Handbook of Animal Models of Infection, O. Zak, M. A. Sande, Eds. (Academic Press, London, 1999), chap. 58, pp. 495-500.
44. O. Gonzalez-Perez, H. Guerrero-Cazares, A. Quiñones-Hinojosa, Targeting of deep brain structures with microinjections for delivery of drugs, viral vectors, or cell transplants. J. Vis. Exp., 2082 (2010).
45. M. L. van Ogtrop, H. Mattie, H. F. Guiot, E. van Strijen, A. M. Hazekamp-van Dokkum, R. van Furth, Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo. Antimicrob. Agents Chemother. 34, 1932-1937 (1990).